IRIS - Res&Arch Institutional Research Information System - Research & Archive

GRESELE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.052
EU - Europa 6.862
AS - Asia 2.819
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 6
OC - Oceania 3
Totale 17.756
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.025
IE - Irlanda 1.679
UA - Ucraina 1.643
HK - Hong Kong 1.189
IT - Italia 1.095
SE - Svezia 767
SG - Singapore 553
VN - Vietnam 468
RU - Federazione Russa 385
DE - Germania 378
FI - Finlandia 371
CN - Cina 315
TR - Turchia 192
FR - Francia 147
GB - Regno Unito 145
CH - Svizzera 54
BE - Belgio 35
KR - Corea 32
PL - Polonia 29
AT - Austria 26
NL - Olanda 25
UZ - Uzbekistan 25
CA - Canada 21
LB - Libano 21
CZ - Repubblica Ceca 18
GR - Grecia 17
ES - Italia 13
EU - Europa 13
MK - Macedonia 11
RO - Romania 10
IN - India 8
BG - Bulgaria 6
MX - Messico 5
PH - Filippine 5
JP - Giappone 4
RS - Serbia 4
IR - Iran 3
PY - Paraguay 3
AU - Australia 2
CL - Cile 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BR - Brasile 1
CR - Costa Rica 1
ID - Indonesia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
Totale 17.756
Salva come PNG Salva come JPEG
Città #
Chandler 1.785
Dublin 1.669
Hong Kong 1.186
San Mateo 908
Jacksonville 903
Dong Ket 467
Altamura 436
Medford 417
Princeton 416
Singapore 345
Lawrence 313
Wilmington 291
Perugia 280
Ann Arbor 265
Des Moines 226
Andover 212
Izmir 191
Saint Petersburg 139
Beijing 136
Ashburn 77
Norwalk 77
Los Angeles 62
Redmond 55
Dearborn 54
Woodbridge 52
San Paolo di Civitate 46
Helsinki 44
Rome 36
Boardman 35
Brussels 34
New York 31
Shanghai 28
Moscow 27
San Diego 26
Houston 22
Den Haag 19
Falls Church 16
Amelia 13
Auburn Hills 13
Seoul 13
Chicago 12
Milan 12
Narni 11
Collazzone 9
Olomouc 9
Redwood City 9
Valencia 9
Frankfurt Am Main 8
Kraków 8
Lappeenranta 8
Ottawa 8
Timisoara 8
Philadelphia 7
Pisa 7
Kiev 6
Lausanne 6
London 6
Nürnberg 6
Simi Valley 6
Tappahannock 5
Vienna 5
Florence 4
Genoa 4
Homburg 4
Sofia 4
Termoli 4
Toronto 4
Alameda 3
Breia 3
Favara 3
Fernando De La Mora 3
Kunming 3
La Spezia 3
Madrid 3
Menlo Park 3
Padova 3
Paris 3
Parma 3
Phoenix 3
Pune 3
Skopje 3
Southwark 3
Amsterdam 2
Andria 2
Bardovci 2
Bratislava 2
Bucharest 2
Calgary 2
Campobasso 2
Casalbordino 2
Ciampino 2
Clearwater 2
Deiva Marina 2
Edinburgh 2
Falkenstein 2
Frankfurt am Main 2
Fremont 2
Granarolo dell'Emilia e Viadagola 2
Gubbio 2
Imus 2
Totale 11.635
Salva come PNG Salva come JPEG
Nome #
Fisiopatologia dell'emostasi 508
PIASTRINE TRASFETTATE CON MATERIALE GENETICO ESOGENO E MICROPARTICELLE DERIVATE DA DETTE PIASTRINE TRASFETTATE, METODO PER LA LORO PREPARAZIONE E LORO USI. 180
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 121
Misurazione del PAF (fattore attivante le piastrine) nella saliva umana; standardizzazione del metodo 106
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 105
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 102
Impact of Chronic Antiplatelet Therapy prior to Hospitalization on Ischemic and Bleeding Events in Invasively Managed Patients with Acute Coronary Syndromes: The ACUITY Trial 98
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 91
Albumin prevents TxB2 formation from thrombin-stimulated human platelets by sequestring the liberated arachidonic acid in the extracellular space 88
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. 84
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 84
Tardive gestosis: clinical observations. 83
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 82
5-ASA-glutamate protects rats from inflammaory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid. 82
Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. 81
Abstract 15389: High On-Treatment Platelet Reactivity in Clopidogrel-Treated Patients Undergoing Elective Carotid Stenting: Correlation with Previous Cerebrovascular Events 80
Platelets are essential for leukocyte recruitment in allergic inflammation. 78
Nitric oxide and its antithrombotic action on the cardiovascular system 77
C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture. 76
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 76
Guida alla terapia antitrombotica curata dalla Federazione Nazionale Centri per la Diagnosi della Trombosi e la Sorveglianza delle Terapie Antitrombotiche (FCSA) 75
[Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention]. 71
Peripheral arteriopathy: effects of cloricromene on claudication and quality of life, a randomized double blind,,placebo controlled trial in patients treated with aspirin 71
Beta 1-tubulin in human platelets: not simply a structural cell frame. 71
Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation. 71
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 70
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 70
Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. 69
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. 69
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 69
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 68
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 68
Arterite temporale occulta: contributo casistico e revisione della letteratura 68
Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma 68
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 67
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant. 67
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 67
Heparin in the prophylaxis and treatment of venous thromboembolism and other thrombotic diseases. 67
Farmaci antitrombossano sintetasi ed antagonisti dei recettori per il trombossano. 67
Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia 67
A novel congenital dysprothrombinemia leading to defective prothrombin maturation. 66
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 66
Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. 66
Platelets 65
Diagnosis of platelet-type von Willebrand disease by flow cytometry. 65
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 65
A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without. 65
Antiplatelet agents in clinical practice and their haemorrhagic risk. 64
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. 64
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 64
HIV type 1 infection, and not short-term HAART, indice endothelial dysfunction. 63
Activation of phospholipase A2 and ß-thromboglobulin release in human platelets stimulated with thrombin and fluoro aluminate 63
Anti-platelet therapy: phosphodiesterase inhibitors. 63
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 63
Intracellular signal transduction mechanisms regulating the release of lysosomes by activated human platelets 63
Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. 61
Effect of cloricromene on intermittent claudication. A randomized double-blind, placebo controlled trial in patients treated with aspirin: effect on claudication distance and quality of life 61
Effects of resveratrol and other wine polyphenols on vascular function: an update. 61
Antithrombotic potential of thromboxane synthase inhibitors: problems and possible solutions 61
Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. 61
Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. 61
Cloricromene inhibits G-Protein mediated activation of phospholipase A2 in human platelets 60
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 60
Matrix metalloproteinases and peripheral arterial disease. 59
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 59
Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients. 59
Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the rule. 59
Kidney failure and endothelial disfunction: effects of haemodialysis 58
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 58
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. 58
Acetylsalicylic acid, BM 13.177 and picotamide improve the survival of endotoxin-infused rabbits 58
Effect of substituted stilbenes on platelet function 58
Allergen induces the migration of platelets to lung tissue in allergic asthma. 57
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 56
Effect of nitric oxide-donating agents on human monocyte cyclooxygenase-2. 56
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry. 56
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 56
Splenic irradiation versus splenectomy for severe, refractory HIV-related thrombocytopenia: Effects on platelet counts and immunological status 55
In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression: a marker of platelet activation 55
Effect of different plasma expanders on erythrocyte filterability 55
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 55
A new case of acquired Glanzmann's thrombasthenia: Diagnostic value of flow cytometry. 54
Endothelium, venous thromboembolism and ischaemic cardiovascular events. 54
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 54
Case Report: Sequestro polmonare in un paziente con emofilia a grave HIV positivo. 54
Comparative evaluation of the fully automated HemosIL®AcuStar ADAMTS13 activity assay vs. ELISA: Possible interference by autoantibodies different from anti ADAMTS-13 54
Impact of prior chronic antiplatelet therapy on short- and long-term adverse events in patients presenting with an acute coronary syndrome: insights from the ACUITY trial. 53
Inherited disorders and gene regulation of platelet signal transduction: the picture is expanding. 53
Critical limb ischemia. 53
Incomplete inhibition of platelet function as assessed by the platelet function analyzer (PFA-100) identifies a subset of cardiovascular patients with high residual platelet response while on aspirin. 53
I peptidil leucotrieni regolano la secrezione di pepsinogeno e la mobilitazione del calcio nelle cellule principali isolate 53
Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH. 53
Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders. 53
Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism. 52
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. 52
Antivasocontrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism. 52
Inhibitors of the interaction between von Willebrand Factor and GPIb/V/IX 52
Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH 52
A novel variant Glanzmann thrombasthenia due to co-inheritance of a loss- and a gain-of-function mutation of ITGB3: evidence of a dominant effect of gain-of-function mutations. 52
Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples. 51
Totale 7.144
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.006
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201928 0 0 0 0 0 0 0 0 0 0 0 28
2019/20201.479 41 23 239 13 240 53 271 28 299 138 36 98
2020/20213.403 28 255 90 254 1.009 135 279 28 397 110 300 518
2021/20223.202 75 631 79 129 104 22 37 1.001 43 113 417 551
2022/20235.971 463 1.155 97 451 461 684 6 253 2.131 19 161 90
2023/20242.648 138 203 121 41 29 13 1.019 52 220 99 413 300
Totale 18.511